Completing the Arc: Targeted Inhibition of RET in Medullary Thyroid Cancer

被引：16
|
作者：
Houvras, Yariv [1 ,2 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] New York Presbyterian Hosp, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 02期
关键词：
MUTATIONS; CARCINOMAS; VANDETANIB; GENETICS; DISEASE; ZD6474;
D O I：
10.1200/JCO.2011.38.7639
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 202
页数：3
相关论文
共 50 条
  • [31] Medullary Thyroid Cancer: New Targeted Molecular Therapies
    Antonelli, Alessandro
    Ferrari, Silvia Martina
    Fallahi, Poupak
    Minuto, Michele
    Corrado, Alda
    Bruno, Rossella
    Miccoli, Paolo
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2010, 4 (01) : 10 - 14
  • [32] Medullary Thyroid Cancer: A Promising Model for Targeted Therapy
    Torino, F.
    Paragliola, R. M.
    Barnabei, A.
    Corsello, S. M.
    CURRENT MOLECULAR MEDICINE, 2010, 10 (07) : 608 - 625
  • [33] Treating medullary thyroid cancer in the age of targeted therapy
    Cabanillas, Maria E.
    Hu, Mimi I.
    Jimenez, Camilo
    Grubbs, Elizabeth G.
    Cote, Gilbert J.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2014, 1 (02) : 203 - 216
  • [34] Targeted Systemic Radiotherapy of Pheochromocytoma and Medullary Thyroid Cancer
    Divgi, Chaitanya
    SEMINARS IN NUCLEAR MEDICINE, 2011, 41 (05) : 369 - 373
  • [35] Medullary thyroid carcinoma in a child with a new RET mutation and a RET polymorphism
    Vandenbosch, K
    Renard, M
    Uyttebroeck, A
    Sciot, R
    Matthijs, G
    Legius, E
    GENETIC COUNSELING, 2005, 16 (01): : 95 - 100
  • [36] Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway
    Samadi, Abbas K.
    Bazzill, Joseph
    Zhang, Xuan
    Gallagher, Rob
    Zhang, Hauping
    Gollapudi, Rao
    Kindscher, Kelly
    Timmermatm, Barbara
    Cohen, Mark S.
    SURGERY, 2012, 152 (06) : 1238 - 1246
  • [37] Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET
    Sahakian, Nicolas
    Castinetti, Frederic
    Romanet, Pauline
    CANCERS, 2023, 15 (19)
  • [38] Crude annual incidence rate of medullary thyroid cancer and RET mutation frequency
    Milicevic, Sara
    Bergant, Damijan
    Zagar, Tina
    Peric, Barbara
    CROATIAN MEDICAL JOURNAL, 2021, 62 (02) : 110 - 119
  • [39] Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib
    Elisei, Rossella
    Ciampi, Raffaele
    Matrone, Antonio
    Prete, Alessandro
    Gambale, Carla
    Ramone, Teresa
    Simeakis, George
    Materazzi, Gabriele
    Torregrossa, Liborio
    Ugolini, Clara
    Romei, Cristina
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (08): : 2195 - 2202
  • [40] A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo
    Samadi, Abbas K.
    Mukerji, Ridhwi
    Shah, Anuj
    Timmermann, Barbara N.
    Cohen, Mark S.
    SURGERY, 2010, 148 (06) : 1228 - 1236
12345